Full Text
Does The Presence of An Orphan Drug Polcy Affect HTA Recommendations For Oncologic Orphan Drugs?

Abstract

Authors

J Riemer R Hancock-Howard A Gauthier

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×